Sentences with phrase «stage biopharmaceutical company»

Kiadis Pharma is a clinical stage biopharmaceutical company developing innovative products to make bone marrow transplantations safer.

Arsanis is a clinical - stage biopharmaceutical company developing targeted monoclonal antibodies for pre-emptive and post-infection treatment of serious infectious diseases.

Pulmatrix, Inc. (PULM) From The Konlin Letter Pulmatrix, Inc. (PULM) is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease.

Nektar Therapeutics, Inc. is clinical - stage biopharmaceutical Company, which is engaged in the development of drug candidates that utilize its PEGylation & advanced polymer conjugate technology platforms.

Acceleron Pharma, Inc. is a clinical stage biopharmaceutical company.

Synergy Pharmaceuticals, Inc. is a development stage biopharmaceutical company, whose main focus is on the development of drugs to treat GI disorders and diseases.

NGM Bio is a research - driven, clinical stage biopharmaceutical company with a drug discovery platform that has generated a pipeline of first - in - class biologic development candidates.

Starting operations in 2012, iTeos Therapeutics is a clinical - stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by developing immunotherapies by design.

Apexigen is a clinical - stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for oncology, with an emphasis on new immuno - oncology agents that could harness the patient's immune system to combat and eradicate cancer.

About CytomX Therapeutics CytomX Therapeutics is a clinical - stage biopharmaceutical company with a deep and differentiated oncology pipeline of investigational Probody ™ therapeutics.

NEW YORK AND SAN DIEGO (Sept. 3, 2014)-- The nonprofits Ludwig Cancer Research (Ludwig) and the Cancer Research Institute (CRI) announced today an agreement with VentiRx Pharmaceuticals Inc., a clinical stage biopharmaceutical company, to conduct a clinical trial with motolimod (VTX - 2337) combined with other immunotherapy agents available to Ludwig and CRI through other industry partnerships.

ura Oncology Inc., a clinical stage biopharmaceutical company that develops therapies for cancer patients, is now trading on the NASDAQ after an initial public offering.

About VentiRx VentiRx Pharmaceuticals Inc. is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll - like receptor 8 (TLR8) immunotherapies for the treatment of cancer, respiratory and inflammatory diseases.

Syndax Pharmaceuticals, Inc. («Syndax,» the «Company» or «we»)(Nasdaq: SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX - 6352 in multiple cancer indications, in collaboration with The Wistar Institute and Indiana University Melvin and Bren Simon Cancer Center, today announced the publication of a preclinical report demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (MDSCs).

The clinical - stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life - altering central nervous system (CNS) disorders, SAGE Therapeutics Inc. (NASDAQ: SAGE) seem to be poised for a price surge as per its latest charts.

Maastricht, The Netherlands, 1 November 2017 — Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, announced today that it has begun a Phase 1b...

SOUTH SAN FRANCISCO, CA — July 25, 2017 — Kezar Life Sciences, a private, clinical - stage biopharmaceutical company developing novel small molecule therapeutics targeting the immunoproteasome and the protein secretion pathway, announced today that it has closed an oversubscribed Series B investment round of $ 50 million led by Cormorant Asset Management and Morningside Venture.

• Aptinyx Inc., an Evanston, Ill. - based clinical - stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, raised $ 70 million in Series B funding.

CalciMedica is a privately - held, clinical stage biopharmaceutical company focused on CRAC channel drug discovery and development for the treatment of acute and chronic inflammatory diseases.

Bellicum is a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders.

HOUSTON, April 16, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock.

HOUSTON, April 17, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of $ 7.50 per share.

• Arsanis, a Waltham, Mass. - based clinical stage biopharmaceutical company focused on monoclonal antibodies, raised $ 40 million in an offering of 4 million shares at $ 10 a piece, below its $ 15 to $ 17 range.

Alder BioPharmaceuticals, Inc., is a clinical - stage biopharmaceutical company committed to transforming the treatment paradigm for patients with migraine and other serious neurological or inflammatory conditions.

Prior to Ambrx, Dr. Kiener was President and Co-founder of Zyngenia Inc., an early - stage biopharmaceutical company.

Prior to Sucampo, he served as Chief Scientific Officer of Ambrx Inc., a clinical - stage biopharmaceutical company focused on the development of antibody - drug conjugates (ADCs) that was acquired by a consortium led by Fosun Pharmaceutical Group in 2015.

Acceleron is a Cambridge - based, clinical - stage biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases.

• Clementia Pharmaceuticals, a Montreal, Canada - based clinical stage biopharmaceutical company focused on bone diseases, filed for an IPO to raise $ 115 million.

• UroGen Pharma, an Israel - based clinical stage biopharmaceutical company, announced terms for its IPO.

HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant to the underwriters» full exercise of their option to purchase additional shares, at a public offering price of $ 7.50 per share.

• BridgeBio Pharma, a Palo Alto, Calif. - based clinical - stage biopharmaceutical company, raised $ 135 million in funding.

Not exact matches

Prior to Corixa, Mr. Christianson served for 12 years overseeing manufacturing and site operations at RIBI ImmunoChem Research, a biopharmaceutical company developing late - stage adjuvant technology.

PNP Therapeutics ®, Inc., is an early - stage, biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer.

Vyriad is a clinical stage, biopharmaceutical company based in Rochester, Minn., that specializes in the development of powerful oncolytic virus therapies, using engineered viruses designed to selectively and rapidly destroy cancer.

NanoViricides, Inc., a development stage nano - biopharmaceutical company, engages in the discovery, development, and commercialization of anti-viral therapeutics primarily in the United States.